Neuro-Oncology Reviews

Volume 24 Number 4
28 February 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 4, 28 February

Ricciardi L, Sturiale CL, Scerrati A, Stifano V, Somma T, Ius T, Trungu S, Acqui M, Raco A, Miscusi M, Della Pepa GM.
5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis.
Front Oncol. 2022 Feb 17;12:848036→. doi: 10.3389/fonc.2022.848036→. PMID: 35252015→. Meta-analysis. ˍ

Villagrán-García M, Velasco R.
Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice.
Neurol Sci. 2022 Feb 17;43(4):2339-2361→. doi: 10.1007/s10072-022-05920-4→. PMID: 35175441→. Review˰ ˍ

Frosina G.
Improving control of high-grade glioma by ultra-hyper-fractionated radiotherapy.
J Neurosci Res. 2022 Feb 20;100(4):933-946→. doi: 10.1002/jnr.25030→. PMID: 35184314→. Review˰ ˍ

Oishi T, Koizumi S, Kurozumi K.
Molecular Mechanisms and Clinical Challenges of Glioma Invasion.
Brain Sci. 2022 Feb 20;12(2):291→. doi: 10.3390/brainsci12020291→. PMID: 35204054→. Review. ˍ

Lin YJ, Mashouf LA, Lim M.
CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future.
Front Immunol. 2022 Feb 21;13:817296→. doi: 10.3389/fimmu.2022.817296→. PMID: 35265074→. Review. ˍ

Low JT, Ostrom QT, Cioffi G, Neff C, Waite KA, Kruchko C, Barnholtz-Sloan JS.
Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians.
Neurooncol Pract. 2022 Feb 22;9(3):165-182→. doi: 10.1093/nop/npac015→. PMID: 35601966→. Review. ˍ

Persico P, Lorenzi E, Losurdo A, Dipasquale A, Di Muzio A, Navarria P, Pessina F, Politi LS, Lombardi G, Santoro A, Simonelli M.
Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations.
Cancers (Basel). 2022 Feb 22;14(5):1125→. doi: 10.3390/cancers14051125→. PMID: 35267433→. Review. ˍ

Verger A, Kas A, Darcourt J, Guedj E.
PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area.
Cancers (Basel). 2022 Feb 22;14(5):1103→. doi: 10.3390/cancers14051103→. PMID: 35267411→. Review. ˍ

Bryukhovetskiy I.
Cell-based immunotherapy of glioblastoma multiforme.
Oncol Lett. 2022 Feb 23;23(4):133→. doi: 10.3892/ol.2022.13253→. PMID: 35251352→. Review. ˍ

Carrete LR, Young JS, Cha S.
Advanced Imaging Techniques for Newly Diagnosed and Recurrent Gliomas.
Front Neurosci. 2022 Feb 23;16:787755→. doi: 10.3389/fnins.2022.787755→. PMID: 35281485→. Review. ˍ

Germano IM, Ziu M, Wen P, Ormond DR, Olson JJ.
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults.
J Neurooncol. 2022 Feb 23;158(2):225-253→. doi: 10.1007/s11060-021-03900-w→. PMID: 35195819→. Guidelines˰ ˍ

Hu H, Chen Y, Tan S, Wu S, Huang Y, Fu S, Luo F, He J.
The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment.
Front Immunol. 2022 Feb 23;13:802846→. doi: 10.3389/fimmu.2022.802846→. PMID: 35281003→. Review. ˍ

Zhai D, An D, Wan C, Yang K.
Radiotherapy: Brightness and darkness in the era of immunotherapy.
Transl Oncol. 2022 Feb 23;19:101366→. doi: 10.1016/j.tranon.2022.101366→. PMID: 35219093→. Review˰ ˍ

Park JH, Lee HK.
Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy.
Cancers (Basel). 2022 Feb 24;14(5):1176→. doi: 10.3390/cancers14051176→. PMID: 35267480→. Review. ˍ

*

Shi Y, Luo J, Wang X, Zhang Y, Zhu H, Su D, Yu W, Tian J.
Emerging Trends on the Correlation Between Neurotransmitters and Tumor Progression in the Last 20 Years: A Bibliometric Analysis via CiteSpace.
Front Oncol. 2022 Feb 24;12:800499→. doi: 10.3389/fonc.2022.800499→. PMID: 35280754→. Bibliometric analysis: ˍ ˍ

Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2022 Feb 25→. NCBI Bookshelf ID: NBK65812→. PMID: 26389253→. Review. ˍ

Bale TA, Rosenblum MK.
The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Brain Pathol. 2022 Feb 25;32(4):e13060→. doi: 10.1111/bpa.13060→. PMID: 35218102→. Review. ˍ

Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2022 Feb 25→. NCBI Bookshelf ID: NBK65981→. PMID: 26389418→. Review. ˍ

Ma W, Sheng X, Li G, Wei Q, Zhou Z, Qiu X.
Effectiveness of different treatment strategies in elderly patients with glioblastoma: an evidence map of randomised controlled trials.
Crit Rev Oncol Hematol. 2022 Feb 25;173:103645→. doi: 10.1016/j.critrevonc.2022.103645→. PMID: 35227898→. Review˰ ˍ

Pancholi S, Tripathi A, Bhan A, Acharya MM, Pillai P.
Emerging Concepts on the Role of Extracellular Vesicles and Its Cargo Contents in Glioblastoma-Microglial Crosstalk.
Mol Neurobiol. 2022 Feb 25;59(5):2822-2837→. doi: 10.1007/s12035-022-02752-3→. PMID: 35212938→. Review˰ ˍ

Alamer OB, Palmisciano P, Rowe SE, Gupta AD, Haider M, Alduhaymi M, Cohen-Gadol AA, Yu K, El-Ahmadieh TY, Haider AS.
Pineal Region Gliomas: A Systematic Review of Clinical Features and Treatment Outcomes.
Anticancer Res. 2022 Feb 26;42(3):1189-1198→. doi: 10.21873/anticanres.15585→. PMID: 35220208→. Review. ˍ

Esemen Y, Awan M, Parwez R, Baig A, Rahman S, Masala I, Franchini S, Giakoumettis D.
Molecular Pathogenesis of Glioblastoma in Adults and Future Perspectives: A Systematic Review.
Int J Mol Sci. 2022 Feb 26;23(5):2607→. doi: 10.3390/ijms23052607→. PMID: 35269752→. Review. ˍ

Sargaço B, Oliveira PA, Antunes ML, Moreira AC.
Effects of the Ketogenic Diet in the Treatment of Gliomas: A Systematic Review.
Nutrients. 2022 Feb 27;14(5):1007→. doi: 10.3390/nu14051007→. PMID: 35267981→. Review. ˍ

Booth TC, Wiegers EC, Warnert EAH, Schmainda KM, Riemer F, Nechifor RE, Keil VC, Hangel G, Figueiredo P, Álvarez-Torres MDM, Henriksen OM.
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics.
Front Oncol. 2022 Feb 28;11:811425→. doi: 10.3389/fonc.2021.811425→. PMID: 35340697→. Review. ˍ